|
|
 |
|
Viewing report
|
|
|
|
BTG International Ltd - Product Pipeline Review - Q4 2010
Global Markets Direct, Dec 2010, Pages: 93
BTG International Ltd – Product Pipeline Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “BTG International Ltd - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- BTG International Ltd - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of BTG International Ltd human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of BTG International Ltd with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the BTG International Ltd’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate BTG International Ltd’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of BTG International Ltd in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the BTG International Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with BTG International Ltd.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of BTG International Ltd and identify potential opportunities in those areas.
|
|
|
|
